- Drug-Device integration and interactions
- Container-Closure/Device interface
- Tissue/Needle interface
- Current challenges and potential pathways
- High dose delivery
- Large volume injections
- Injection tolerability
- Delivery/device preference
- Concluding remarks and a look into the future
Drug delivery is a complex subject that requires the interdisciplinary engagement of various science and technology functions as well as the discipline of project management to effectively drive the development and commercialization of drug-device combination products to the market.
Andrew Ratz, Senior Vice President, Drug Delivery and Device Development, Eli Lilly and Company
